Benefits of once-daily therapies in the treatment of hypertension
- PMID: 22241952
- PMCID: PMC3253771
- DOI: 10.2147/VHRM.S17207
Benefits of once-daily therapies in the treatment of hypertension
Abstract
In patients with hypertension, 24-hour blood pressure control is the major therapeutic goal. The number of daily doses is one characteristic of an antihypertensive agent that may affect the adequacy of 24-hour control. One measure of therapeutic coverage is the 24-hour trough-to-peak ratio, which determines the suitability of an agent for once-daily administration. The closer an agent is to a 100% trough-to-peak ratio, the more uniform the 24-hour coverage and therefore blood pressure control. High trough-to-peak ratio, long-acting antihypertensive medications lower blood pressure more gradually, which reduces the likelihood of adverse events attributable to abrupt drug action that occurs with shorter-acting agents. In hypertension, the natural diurnal variation of blood pressure may be altered, including elevated nighttime pressures. An optimal once-daily hypertension therapy would not only lower blood pressure but also normalize any blunted circadian variations in blood pressure. The benefits of once-daily agents with sustained therapeutic coverage may also be explained, in part, by increased patient adherence to simpler regimens as well as lower loss of blood pressure control during virtually inevitable intermittent noncompliance. Studies have demonstrated that once-daily antihypertensive agents have the highest adherence compared with twice-daily or multiple daily doses, including greater adherence to the prescribed timing of doses.
Keywords: adherence; blood pressure control; therapeutic coverage.
Figures


Similar articles
-
Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs.J Hypertens Suppl. 1995 Aug;13(2):S109-12. doi: 10.1097/00004872-199508001-00018. J Hypertens Suppl. 1995. PMID: 8576780 Review.
-
Goals of antihypertensive therapy.Drugs. 1995 Feb;49(2):161-75. doi: 10.2165/00003495-199549020-00002. Drugs. 1995. PMID: 7729325 Review.
-
Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.Am J Cardiol. 1996 Jul 1;78(1):51-5. doi: 10.1016/s0002-9149(96)00226-3. Am J Cardiol. 1996. PMID: 8712118 Clinical Trial.
-
Using fixed-dose combination therapies to achieve blood pressure goals.Clin Drug Investig. 2008;28(11):713-34. doi: 10.2165/00044011-200828110-00005. Clin Drug Investig. 2008. PMID: 18840014 Review.
-
Effects of dividing amlodipine daily doses on trough drug concentrations and blood pressure control over a 24-hour period.Clin Ther. 2013 Sep;35(9):1418-22. doi: 10.1016/j.clinthera.2013.07.428. Epub 2013 Aug 22. Clin Ther. 2013. PMID: 23972579 Clinical Trial.
Cited by
-
Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?Vasc Health Risk Manag. 2013;9:125-33. doi: 10.2147/VHRM.S33515. Epub 2013 Mar 24. Vasc Health Risk Manag. 2013. PMID: 23569382 Free PMC article. Review.
-
An assessment of treatment compliance using the Morisky scale-8 tool in adult hypertensive patients of Eastern India.J Family Med Prim Care. 2024 Mar;13(3):924-931. doi: 10.4103/jfmpc.jfmpc_1416_23. Epub 2024 Apr 4. J Family Med Prim Care. 2024. PMID: 38736807 Free PMC article.
-
Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study.Egypt Heart J. 2020 Mar 4;72(1):9. doi: 10.1186/s43044-020-00045-5. Egypt Heart J. 2020. PMID: 32130547 Free PMC article.
-
Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient.Ther Adv Chronic Dis. 2022 Jun 24;13:20406223221102754. doi: 10.1177/20406223221102754. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35769133 Free PMC article. Review.
-
Beating against the clock.Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2558-9. doi: 10.1073/pnas.1601161113. Epub 2016 Feb 23. Proc Natl Acad Sci U S A. 2016. PMID: 26908876 Free PMC article. No abstract available.
References
-
- Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252. - PubMed
-
- Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56(5):780–800. - PubMed
-
- Zannad F. Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs. J Hypertens Suppl. 1995;13(2):S109–112. - PubMed
-
- Meredith PA, Elliott HL. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. J Cardiovasc Pharmacol. 1994;23(Suppl 5):S26–30. - PubMed
-
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical